CIEPLINSKA AGNIESZKA (VP FINANCE, CONTROLLER (PAO)) sold 11.1% of their position (947.00 shares) of MOMENTA PHARMACEUTICALS INC on the open market
Open‑market sale worth $33.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/1/2020ACC: 0001104659-20-080019
Officer· VP FINANCE, CONTROLLER (PAO)
Since Jan 2020
+5.35K
Net shares
Net buyer
$33.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.30K acquired · 947.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.15K
Price / share
—
Trade value
—
% of position
58.6%
6/29/2020
5.37K→8.52K
Common Stock
Direct
Shares
−947.00
Price / share
$35.11
Trade value
$33.25K
% of position
11.1%
6/30/2020
8.52K→7.57K
Total
Net shares
+2.20K
Net value
-$33.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/29/2020 | A · Award | +3.15K | — | — | 58.6% | 5.37K | 8.52K |
| Common Stock Direct | 6/30/2020 | S · Sale | −947.00 | $35.11 | $33.25K | 11.1% | 8.52K | 7.57K |
| Total | +2.20K | -$33.25K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
3.15K shares
Shares
+3.15K
Strike price
Held after
9.45K
Exercisable
—
6/29/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock3.15K shares | 6/29/2020 | A · Award | +3.15K | — | 9.45K |